F
Foghorn Therapeutics Inc.
FHTX · NASDAQ · Healthcare · 368M
Price · close
$7.07
+0.86% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-5.7×
Free cash flow yieldFCF yield
-19.3%
Return on equityROE
68.5%
Operating margin
-265.6%
Net debt / EBITDAbalance-sheet strength
0.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.